In-kind
Capital Access Advisory Program (CAAP)
The OBIO® Capital Access Advisory Program (CAAP®) is a competitive, 9–12 month structured initiative designed to help health science companies prepare for Series A financing and strategic partnerships. The program provides strategic business planning, advanced fundraising strategies, and support in closing investment deals. Participating companies benefit from investor introductions, business development support, networking, and the opportunity to present at the OBIO® Investment Summit.
- 4.5/5.0
- Ontario Bioscience Innovation Organization (OBIO)
- All levels
- Last updated 5 months ago
- English
Description
The OBIO® Capital Access Advisory Program (CAAP®) is a competitive, 9–12 month structured initiative designed to help health science companies prepare for Series A financing and strategic partnerships. The program provides strategic business planning, advanced fundraising strategies, and support in closing investment deals. Participating companies benefit from investor introductions, business development support, networking, and the opportunity to present at the OBIO® Investment Summit.To accelerate commercialization for high-potential Ontario health science companies by preparing them for successful Series A financing and strategic growth.